The Europe Enteral Syringe Market would witness market growth of 4.9% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Enteral Syringe Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $39,862.1 Thousands by 2031. The UK market is exhibiting a CAGR of 4.3% during (2024 - 2031). Additionally, The France market would experience a CAGR of 5.7% during (2024 - 2031).
These syringes administer fluids to patients who cannot drink enough water or other liquids. This is especially important in conditions that lead to dehydration, such as gastrointestinal diseases, fever, or after surgery. Patients with electrolyte imbalances can benefit from fluid solutions containing electrolytes, which can be administered through these syringes. This helps in restoring proper fluid and electrolyte balance in the body. Both children and elderly patients may require these syringes for hydration due to difficulty consuming fluids. This ensures they receive adequate hydration to support their health and recovery.
Furthermore, these syringes deliver nutrition and medications through gastrostomy (G-tube) or jejunostomy (J-tube) tubes. These tubes are inserted directly into the stomach or small intestine, allowing direct access to the gastrointestinal tract. Regular flushing feeding tubes with water or other fluids is necessary to prevent blockages and ensure proper functioning. These syringes are used for this purpose, helping maintain the tubes’ patency. Some patients require specialized nutritional formulas to be delivered through feeding tubes. These syringes facilitate precisely delivering these feeds according to the patient’s dietary needs.
With an increase in paediatric cases, European healthcare systems may allocate more resources towards paediatric care, including enteral nutrition. This growth in healthcare expenditure can drive the demand for enteral syringes as part of broader investments in paediatric healthcare. As per the Eurostat, 4.4 % of children in the EU reported a disability (activity limitation due to health problems) in 2021. 3.4 % of children had a moderate disability, and 1.0 % had severe disability. About 4 % of EU children had unmet medical care needs in 2021. Thus, presence of the paediatric conditions in the region is driving the growth of the market.
Free Valuable Insights: The Global Enteral Syringe Market will Hit USD 556.9 Million by 2031, at a CAGR of 5.1%
Based on Age Group, the market is segmented into Adults and Pediatrics. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Homecare. Based on Type, the market is segmented into Disposable and Reusable. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
By Age Group
By End User
By Type
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 